Stanford I M, Cooper A J
The Department of Pharmacology, The Division of Neuroscience, The Medical School, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.
J Neurosci. 1999 Jun 15;19(12):4796-803. doi: 10.1523/JNEUROSCI.19-12-04796.1999.
The role of enkephalin and the opioid receptors in modulating GABA release within the rat globus pallidus (GP) was investigated using whole-cell patch recordings made from visually identified neurons. Two major GP neuronal subtypes were classified on the basis of intrinsic membrane properties, action potential characteristics, the presence of the anomalous inward rectifier (Ih), and anode break depolarizations. The mu opioid receptor agonist [D-Ala2-N-Me-Phe4-Glycol5]-enkephalin (DAMGO) (1 microM) reduced GABAA receptor-mediated IPSCs evoked by stimulation within the striatum. DAMGO also increased paired-pulse facilitation, indicative of presynaptic mu opioid receptor modulation of striatopallidal input. In contrast, the delta opioid agonist D-Pen-[D-Pen2, 5]-enkephalin (DPDPE) (1 microM) was without effect. IPSCs evoked by stimulation within the GP were depressed by application of [methionine 5']-enkephalin (met-enkephalin) (30 microM). Met-enkephalin also reduced the frequency, but not the amplitude, of miniature IPSCs (mIPSCs) and increased paired-pulse facilitation of evoked IPSCs, indicative of a presynaptic action. Both DAMGO and DPDPE reduced evoked IPSCs and the frequency, but not amplitude, of mIPSCs. However, spontaneous action potential-driven IPSCs were reduced in frequency by met-enkephalin and DAMGO, whereas DPDPE was without effect. Overall, these results indicate that presynaptic mu opioid receptors are located on striatopallidal terminals and pallidopallidal terminals of spontaneously firing GP neurons, whereas presynaptic delta opioid receptors are preferentially located on terminals of quiescent GP cells. Enkephalin, acting at both of these receptor subtypes, serves to reduce GABA release in the GP and may therefore act as an adaptive mechanism, maintaining the inhibitory function of the GP in basal ganglia circuitry.
利用对视觉识别的神经元进行全细胞膜片钳记录,研究了脑啡肽和阿片受体在调节大鼠苍白球(GP)内γ-氨基丁酸(GABA)释放中的作用。根据内在膜特性、动作电位特征、反常内向整流(Ih)的存在以及阳极断裂去极化,将两种主要的GP神经元亚型进行了分类。μ阿片受体激动剂[D-丙氨酸2-N-甲基苯丙氨酸4-甘醇5]-脑啡肽(DAMGO)(1微摩尔)减少了纹状体内刺激诱发的GABAA受体介导的抑制性突触后电流(IPSCs)。DAMGO还增加了双脉冲易化,表明纹状体苍白球输入存在突触前μ阿片受体调节。相比之下,δ阿片激动剂D-青霉胺-[D-青霉胺2,5]-脑啡肽(DPDPE)(1微摩尔)没有作用。应用[蛋氨酸5']-脑啡肽(甲硫氨酸脑啡肽)(30微摩尔)可抑制GP内刺激诱发的IPSCs。甲硫氨酸脑啡肽还降低了微小抑制性突触后电流(mIPSCs)的频率,但不影响其幅度,并增加了诱发IPSCs的双脉冲易化,表明存在突触前作用。DAMGO和DPDPE均降低了诱发的IPSCs以及mIPSCs的频率,但不影响其幅度。然而,甲硫氨酸脑啡肽和DAMGO降低了自发动作电位驱动的IPSCs的频率,而DPDPE没有作用。总体而言,这些结果表明,突触前μ阿片受体位于自发放电的GP神经元的纹状体苍白球终末和苍白球苍白球终末,而突触前δ阿片受体优先位于静止GP细胞的终末。脑啡肽作用于这两种受体亚型,有助于减少GP内的GABA释放,因此可能作为一种适应性机制,维持GP在基底神经节回路中的抑制功能。